APPLICATION
ANDA209026
TYPE
ANDA
ORIGINAL APPROVAL
2019-06-11
LATEST ACTION
2019-06-11
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 8MEQ · CAPSULE, EXTENDED RELEASE · ORAL
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL
Approval history
2019-06-11UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.